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Introduction
Dengue infection is caused by Flavivirus and spreads
through Aedes aegypti mosquito. The virus infects over 50
million people worldwide, resulting in over 24,000 deaths
annually.1,2 Billions of people remain exposed to the
disease across Africa, Eastern Mediterranean, Southeast
Asia and Western Pacific region.3
Clinical presentation of patients with dengue infection
varies from a self-limiting, non-specific acute febrile illness
to a syndrome characterised by bleeding, severe
intravascular volume depletion and shock.4 Given its
vague presentation, early identification of severe
infections can be challenging, causing delays in the
institution of life-saving interventions. To assist clinicians
in making triage decisions, the World Health Organisation
(WHO) published a dengue infection triage and treatment
guideline in 1997.5 It was based on the data from
paediatric population of Bangkok and divided the clinical
syndrome into dengue fever (DF), dengue haemorrhagic
fever (DHF) and dengue shock syndrome (DSS).6-8 A
revised version of the guideline was published in 2009 to
address the low sensitivity in high-risk patients and was
more inclusive of adult patients as well.2,9,10 The new
classification, while retaining the three-level severity
grading, divided the infection into dengue without
warning signs, dengue with warning signs and severe
dengue.2,6,10
Pakistan has experienced a major epidemic of dengue
infection since 2005.11 Hospitals, especially the
emergency departments (ED), have seen a major surge in
the dengue patient volume. In the beginning of the
epidemic, triage decisions were based on the clinician's
judgment, while WHO guidelines were slowly being
accepted as the decision-making tool. Recently published
studies from other settings have shown better accuracy of
the revised guidelines.2,12,13 This study was carried out to
compare the performance of 1997 and 2009 WHO
guidelines based on the dengue Immunoglobulin (IgM)
results in our setting.2,5
Patients and Methods
This was a case series of Dengue patients recruited by
retrospective chart review conducted at the Aga Khan
University Hospital (AKUH) Karachi, Pakistan. All adult
patients with a diagnosis of dengue who had a positive
dengue IgM serology between January 2005 and
December 2007 were included in the study. Cases with
incomplete information such as signs, symptoms and
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laboratory figures were excluded. By using a standard
tool, trained research assistants extracted data
regarding clinical features, laboratory investigations,
on-admission diagnosis in ED and diagnosis of hospital
with serological test (IgM anti-dengue). In our current
clinical setting, we send dengue IgM test on all
suspicious patients. Anti-IgM becomes positive on
the fifth day of dengue illness and can remain
positive for 90 days.
No patient had polymerase chain reaction (PCR) test
or culture of the virus. Each patient was
classified/graded both according to 1997 (Dengue
Fever, Dengue Haemorrhagic Fever and Dengue
Shock Syndrome) and 2009 guidelines (dengue
without warning signs, dengue with warning signs
and severe dengue) (Table-1, Figure-1) by the
research assistant using the standard definitions. The
three categories of dengue used in each of the
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Table-1: WHO guidelines (1999) for the treatment of dengue fever/ dengue hemorrhagic fever.
DF/DHF Grade* Symptoms Laboratory picture
DF Fever with two or more of the following signs: Leukopenia occasionally. Thrombocytopenia may be 
headache, retro -orbital pain, myalgia, arthralgia present. No evidence of plasma loss
DHF I Above signs plus positive tourniquet test Thrombocytopenia positive tourniquet < 100,000, Hct rise > 20%
DHF II Above signs plus spontaneous bleeding Thrombocytopenia < 100,000, Hct rise > 20%
DHF III Above signs plus circulatory failure (weak pulse, hypotension restlessness) Thrombocytopenia < 100,000, Hct rise > 20%
DHF IV Profound shock with undetectable blood pressure and pulse Thrombocytopenia < 100,000, Hct rise > 20%
DHF Grade III and IV are also called as Dengue Shock Syndrome (DSS).
Figure-1: Dengue, guidelines for diagnosis, treatment, prevention and control new edition 2009.
guidelines were referred to as minor, moderate and
severe. Minor dengue was used for DF (1997
guidelines) and dengue without warning signs (2009
guidelines); moderate dengue for DHF (1997) and
dengue with warning signs (2009); and severe dengue
for DSS (1997) and severe dengue (2009).
Descriptive analysis was done using SPSS, version 19.0
and frequencies and percentages were calculated.
Median with interquartile range (IQR) was reported for
skewed data such as age and platelet count, while mean ±
standard deviation (SD) was used for normal data. Ethical
approval was obtained from the institutional ethics
review committee.
Results
A total of 612 patients were located with a diagnosis of
dengue out of which 439 (71.73%) had a positive IgM.
According to 1997 guidelines, 383 (87%) patients were
classified as having dengue. On the other hand, 2009
guidelines classified 439 (100%) patients as dengue
infected (Figure-2). Of the 56 (13%) cases which could not
be labelled as dengue using the 1997 guidelines, 30 (54%)
were classified as probable dengue without warning
signs, 19 (34%) were classified as dengue with warning
signs, and 7 (12%) as severe dengue using the 2009
guidelines.
The median age of the participants was 28 (IQR 18) years;
295 (67%) were males. All patients were discharged from
the hospital except one patient who died in the hospital.
Only 167v(38%) patients had three or more symptoms on
history. Most (n=248; 56%) had no signs on examination
(Table-2). All the patients presented with fever (100%),
vomiting 281 (64%) and body ache 173 (39%). Rash (27%),
petechiae (10%) and purpura (1%) were present in less
number of patients.
Table-3 shows the comparison of both guidelines. The
two guidelines classified approximately 50% of cases
similarly as minor, moderate and severe dengue (Table-2).
WHO 1997 had classified 21 (5.5%) cases as DSS while
2009 guidelines labelled 81 (21%) cases as severe dengue,
with consensus on only 11 (52.4%) severe cases by both
the guidelines. The alarming result was that more than a
quarter cases (29%) that were classified as moderate by
the 1997 guideline were severe dengue according to the
2009 guidelines. 
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Table-2: Clinical features of study population (n = 439).
Clinical Symptoms n(%)
Fever 439 (100)
Vomiting 281(64)
Body ache 173(39)
Abdominal pain 152(35)
Bleeding other than nose and gum 75(17)
Headache 35(8)
Gum Bleed 32(7)
Nose Bleed 26(5)
Haematemesis 22(5)
Drowsiness 21(5)
Shortness of Breadth 14(3)
Examination Findings n(%)
Rash 120(27)
Ascites 44(10)
Petechie 45(10)
Hepatomegaly 19(4)
Pulmonary Effusion 16(4)
Splenomegaly 9(2)
Purpura 6(1)
Vital Examination Readings Mean ± SD
Temperature(oC) 38±3
Systolic Blood Pressure(mm Hg) 112±17
Diastolic Blood Pressure(mm Hg) 72±12
Pulse Pressure(beats/min) 40±14
Laboratory Parameters Mean ± SD
White Blood Count(x109/L)(n=431) 5±4
Haematocrit(gm/dl)(n=426) 41±7
Prothrombin Time(secs)(n=362) 13±8
International Normalized Ratio(n=359) 1±2
Activated Partial Thromboplastin Time(secs)(n=367) 37±20
Sodium(mEq/L)(n=406) 138±75
Bicarbonate(mEq/L)(n=332) 22±5
M e d i a n
(IQR)
Platelet(x109/L)(n=427) 45(67)
Blood Urea Nitrogen(mg/dL)(n=368) 9(6)
Creatinine(mg/dL)(n=409) 1(0.4)
Serum Glutamate-Oxaloacetate Transaminase(units/L)(n=388) 174(274)
Table-3: Comparison of WHO guidelines for dengue cases (n=383).
Disease Severity Disease Severity as per 2009 Classification
as per 1997 Dengue Fever Dengue Haemorrhagic Dengue Shock Total
Classification n(%) Fever n(%) Syndrome n(%) n(%)
Probable Dengue without warning signs 68 (45.3) 48(22.6) 4(19) 120(31.3)
Probable Dengue with warning signs 73(48.7) 103(48.6) 6(28.6) 182(45.7)
Severe dengue 9(6) 61(28.8) 11(52.4) 81(21.1)
Total 150(100) 212(100) 21(100) 383(100)
Discussion
We not only found a difference between 1997 and 2009
guidelines in the accuracy of dengue diagnosis, but also
in the assessment of the severity of the disease.2,5 There
was a four-fold increase in the diagnosis of severe form of
dengue using 2009 guidelines compared to the 1997
guidelines.
The diagnostic challenge is likely to be higher in our
setting where other febrile illnesses are more common.
Diseases such as typhoid fever or malaria contribute to a
major bulk of acute clinical practice in Pakistan and, like
dengue, they often present with non-specific fever, few
signs or symptoms and a blood picture showing low
white blood cell (WBC) and platelet counts.14.15 Atypical
presentations such as abdominal pain, vomiting,
diarrhoea, cough and headache resembling enteric fever
have been reported in other studies from Pakistan,
making clinical decision more difficult.16 In such endemic
settings, concurrent infections such as dengue and
malaria could mislead physician's initial impression.
Coexistence of malaria and dengue have been reported to
be in the range of 20% to as high as 80%.17,18 While
malaria testing is more widely available, diagnostic tests
for dengue (IgM) are either not available or not able to
detect dengue in the first few days of the disease onset,
biasing the clinical diagnosis towards malaria.
Patients in our setting tend to start the use of antibiotic
and other medicines either in consultation with a general
physician or by themselves. In Pakistan, there are no strict
prescription regulations and drugs are easily available
over the counter. Patients visit the hospital only when
their condition deteriorates, and this makes correct
diagnosis challenging for the physicians. 
Time also affects accuracy of diagnosis even when WHO
guidelines are used. Leo et al reported an increase in the
accuracy of diagnosis by the WHO guidelines from 14% to
32% and 61% to 79% from day 1 to day 7 of admission
using the 1997 and 2009 guidelines respectively.13 A
study from Karachi, showed that almost one-fourth of
children with final diagnosis of DF were initially labelled as
undifferentiated fever.19 Similarly, in Vietnam about a third
of cases with DF were initially diagnosed as acute
undifferentiated fever.20
Revised guidelines were found to be better in diagnosing
dengue cases overall, particularly those with severe form
of illness. This is corroborated by work done in other
settings, both among adults and children.12,21 DENCO, a
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Figure-2: Flow chart of dengue patients recruitment (January 2005- December 2007).
multi-country prospective study, found comparable
results where 15% of patients with clinical shock were not
correctly classified by 1997 classification as severe cases.22
One reason is, perhaps, paediatric focus of the 1997
guidelines which limited its application to adult
population.7,9,23 The 2009 classification included more
non-specific alarming signs such as mental status
changes, abdominal pains and involvement of other
organs such as liver. 
The current study has several limitations. First, it is based
on the retrospective data obtained from medical records.
Not all features, for example, tourniquet test, were
universally captured in the medical records. Second, we
could not include dengue patients who were
misdiagnosed and sent home and also those who were
sent home because they had mild disease.24 Third, we did
not know if the individual physician applied the
guidelines or was even aware of the guidelines.
Conclusion
By using the WHO guidelines 2009, a physician would end
up classifying more dengue patients as having moderate
or severe disease compared to the 1997 guideline.
Widespread use of these guidelines needs to be
encouraged among physicians.
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